Search Results - cd3-receptor

1 Results Sort By:
T-cell Phenotypes Associated with Clinical Response to Adoptive Immunotherapy
Summary: The NCI seeks applications from parties interested in co-developing and/or licensing a method to develop improved cancer immunotherapies. Description of Technology: Adoptive T-cell therapy (ACT) utilizes tumor-reactive T cells to induce disease remission. While ACT has been used effectively to treat metastatic melanoma and certain epithelial...
Published: 4/24/2026   |   Updated: 8/2/2023   |   Inventor(s): Steven Rosenberg, Gregoire Altan-Bonnet, Sri Krishna, Paul Robbins, Frank Lowery
Keywords(s): act, Adoptive T Cell Therapy, Cancer Immunotherapies, CAR, CD-39 Receptor, CD3-Receptor, CD-69 Receptor, chimeric antigen receptor, Lowery, Rosenberg, T Cell Receptor, TCR, TILS, Tumor-Infiltrating T-Lymphocytes
Category(s): TherapeuticArea > Infectious Disease, TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Therapeutics